Identifying an obinutuzumab resistant subpopulation of monocyte-derived-macrophages from patients with CLL.
2020
Antibody therapies are important treatment options for Chronic lymphocytic leukemia (CLL). Monocyte-derived-macrophages (MDMs) are thought to be a major immune effector that clears leukaemic cells ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
1
Citations
NaN
KQI